PEPlife: A Repository of the Half-life of Peptides
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Short half-life is one of the key challenges in the field of therapeutic peptides. Various studies have reported enhancement in the stability of peptides using methods like chemical modifications, D-amino acid substitution, cyclization, replacement of labile aminos acids, etc. In order to study this scattered data, there is a pressing need for a repository dedicated to the half-life of peptides. To fill this lacuna, we have developed PEPlife (http://crdd.osdd.net/raghava/peplife), a manually curated resource of experimentally determined half-life of peptides. PEPlife contains 2229 entries covering 1193 unique peptides. Each entry provides detailed information of the peptide, like its name, sequence, half-life, modifications, the experimental assay for determining half-life, biological nature and activity of the peptide. We also maintain SMILES and structures of peptides. We have incorporated web-based modules to offer user-friendly data searching and browsing in the database. PEPlife integrates numerous tools to perform various types of analysis such as BLAST, Smith-Waterman algorithm, GGSEARCH, Jalview and MUSTANG. PEPlife would augment the understanding of different factors that affect the half-life of peptides like modifications, sequence, length, route of delivery of the peptide, etc. We anticipate that PEPlife will be useful for the researchers working in the area of peptide-based therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The I-TASSER Suite: protein structure and function prediction
Yang, J., Yan, R., Roy, A., Xu, D., Poisson, J., & Zhang, Y. (2015) · Nature Methods · doi:10.1038/nmeth.3213 · Cited by 5,596
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
APD2: the updated antimicrobial peptide database and its application in peptide design.
Wang, G., Li, X., & Wang, Z. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn823 · Cited by 941
Future directions for peptide therapeutics development
Kaspar, A. A., & Reichert, J. M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.011 · Cited by 750
AVPpred: collection and prediction of highly effective antiviral peptides.
Thakur, N., Qureshi, A., & Kumar, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks450 · Cited by 324
Next-generation peptide vaccines for advanced cancer
Yamada, A., Sasada, T., Noguchi, M., & Itoh, K. (2013) · Cancer Science · doi:10.1111/cas.12050 · Cited by 124
Research works printed but not linked: 44
- Craik, D. J., Fairlie, D. P., Liras, S. & Price, D. The future of peptide-based drugs. Chem Biol Drug Des 81, 136–147, doi: 10.1111/cbdd.12055 (2013). · DOI · Paper page
- Vlieghe, P., Lisowski, V., Martinez, J. & Khrestchatisky, M. Synthetic therapeutic peptides: science and market. Drug Discov Today 15, 40–56, doi: 10.1016/j.drudis.2009.10.009 (2010). · DOI · Paper page
- Lax, R. The future of peptide development in the pharmaceutical industry. PharManufacturing: The international peptide review 2, 10–15 (2010).
- Sun, L. Peptide-based drug development. Mod. Chem. Appl 1 (2013). · DOI
- Waghu, F. H. et al. CAMP: Collection of sequences and structures of antimicrobial peptides. Nucleic Acids Res. 42, D1154–D1158, doi: 10.1093/nar/gkt1157 (2014). · DOI · Paper page
- Qureshi, A., Thakur, N., Tandon, H. & Kumar, M. AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses. Nucleic Acids Res. 42, D1147–D1153, doi: 10.1093/nar/gkt1191 (2014). · DOI · Paper page
- Mehta, D. et al. ParaPep: a web resource for experimentally validated antiparasitic peptide sequences and their structures. Database (Oxford) 2014, doi: 10.1093/database/bau051 (2014). · DOI
- Hammami, R., Ben Hamida, J., Vergoten, G. & Fliss, I. PhytAMP: a database dedicated to antimicrobial plant peptides. Nucleic Acids Res 37, D963–D968, doi: 10.1093/nar/gkn655 (2009). · DOI · Paper page
- Seshadri Sundararajan, V. et al. DAMPD: a manually curated antimicrobial peptide database. Nucleic Acids Res 40, D1108–D1112, doi: 10.1093/nar/gkr1063 (2012). · DOI
- Piotto, S. P., Sessa, L., Concilio, S. & Iannelli, P. YADAMP: yet another database of antimicrobial peptides. Int J Antimicrob Agents 39, 346–351, doi: 10.1016/j.ijantimicag.2011.12.003 (2012). · DOI · Paper page
- Gautam, A. et al. CPPsite: a curated database of cell penetrating peptides. Database (Oxford) 2012, bas015, doi: 10.1093/database/bas015 (2012). · DOI · Paper page
- Wynendaele, E. et al. Quorumpeps database: chemical space, microbial origin and functionality of quorum sensing peptides. Nucleic Acids Res 41, D655–D659, doi: 10.1093/nar/gks1137 (2013). · DOI
- Van Dorpe, S. et al. Brainpeps: the blood-brain barrier peptide database. Brain Struct Funct 217, 687–718, doi: 10.1007/s00429–011–0375–0 (2012). · DOI
- Théolier, J., Fliss, I., Jean, J. & Hammami, R. MilkAMP: a comprehensive database of antimicrobial peptides of dairy origin. Dairy Science & Technology 94, 181–193 (2014). · DOI
- Novkovic, M., Simunic, J., Bojovic, V., Tossi, A. & Juretic, D. DADP: the database of anuran defense peptides. Bioinformatics 28, 1406–1407, doi: 10.1093/bioinformatics/bts141 (2012). · DOI · Paper page
- Zhao, X., Wu, H., Lu, H., Li, G. & Huang, Q. LAMP: A Database Linking Antimicrobial Peptides. PLoS One 8, e66557, doi: 10.1371/journal.pone.0066557 (2013). · DOI · Paper page
- Agrawal, P. et al. CPPsite 2.0: a repository of experimentally validated cell-penetrating peptides. Nucleic Acids Res 44, D1098–D1103, doi: 10.1093/nar/gkv1266 (2016). · DOI · Paper page
- Tyagi, A. et al. CancerPPD: a database of anticancer peptides and proteins. Nucleic Acids Res 43, D837–D843, doi: 10.1093/nar/gku892 (2015). · DOI · Paper page
- McGregor, D. P. Discovering and improving novel peptide therapeutics. Curr Opin Pharmacol 8, 616–619, doi: 10.1016/j.coph.2008.06.002 (2008). · DOI · Paper page
- Dhanda, S. K. et al. Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics. Brief Bioinform, doi: 10.1093/bib/bbw025 (2016). · DOI
- Gautam, A. et al. In silico approaches for designing highly effective cell penetrating peptides. J Transl Med 11, 74, doi: 10.1186/1479–5876–11–74 (2013). · DOI
- Sharma, A. et al. Computational approach for designing tumor homing peptides. Sci Rep 3, 1607, doi: 10.1038/srep01607 (2013). · DOI
- Gupta, S. et al. In silico approach for predicting toxicity of peptides and proteins. PLoS One 8, e73957, doi: 10.1371/journal.pone.0073957 (2013). · DOI · Paper page
- Gautam, A. et al. Hemolytik: a database of experimentally determined hemolytic and non-hemolytic peptides. Nucleic Acids Res 42, D444–D449, doi: 10.1093/nar/gkt1008 (2014). · DOI · Paper page
- Chaudhary, K. et al. A Web Server and Mobile App for Computing Hemolytic Potency of Peptides. Sci Rep 6, 22843, doi: 10.1038/srep22843 (2016). · DOI · Paper page
- Jenssen, H. & Aspmo, S. I. Serum stability of peptides. Methods Mol Biol 494, 177–186, doi: 10.1007/978–1–59745–419–3_10 (2008). · DOI
- Sharma, A., Singla, D., Rashid, M. & Raghava, G. P. Designing of peptides with desired half-life in intestine-like environment. BMC Bioinformatics 15, 282, doi: 10.1186/1471–2105–15–282 (2014). · DOI
- Knappe, D., Henklein, P., Hoffmann, R. & Hilpert, K. Easy strategy to protect antimicrobial peptides from fast degradation in serum. Antimicrob Agents Chemother 54, 4003–4005, doi: 10.1128/AAC.00300–10 (2010). · DOI
- Adessi, C. et al. Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer’s disease. J Biol Chem 278, 13905–13911, doi: 10.1074/jbc.M211976200 (2003). · DOI · Paper page
- Gong, N. et al. Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity. Br J Pharmacol 163, 399–412, doi: 10.1111/j.1476–5381.2011.01227.x (2011). · DOI
- Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res 42, D1091–D1097, doi: 10.1093/nar/gkt1068 (2014). · DOI · Paper page
- Rose, P. W. et al. The RCSB Protein Data Bank: views of structural biology for basic and applied research and education. Nucleic Acids Res 43, D345–D356, doi: 10.1093/nar/gku1214 (2015). · DOI · Paper page
- Singh, S. et al. PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues. Biol Direct 10, 73, doi: 10.1186/s13062–015–0103–4 (2015). · DOI · Paper page
- Kaur, H., Garg, A. & Raghava, G. P. PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides. Protein Pept Lett 14, 626–631 (2007). · DOI · Paper page
- Khoury, G. A. et al. Forcefield_NCAA: ab initio charge parameters to aid in the discovery and design of therapeutic proteins and peptides with unnatural amino acids and their application to complement inhibitors of the compstatin family. ACS Synth Biol 3, 855–869, doi: 10.1021/sb400168u (2014). · DOI
- Khoury, G. A., Thompson, J. P., Smadbeck, J., Kieslich, C. A. & Floudas, C. A. Forcefield_PTM: Charge and AMBER Forcefield Parameters for Frequently Occurring Post-Translational Modifications. J Chem Theory Comput 9, 5653–5674, doi: 10.1021/ct400556v (2013). · DOI
- Gfeller, D., Michielin, O. & Zoete, V. SwissSidechain: a molecular and structural database of non-natural sidechains. Nucleic Acids Res 41, D327–D332, doi: 10.1093/nar/gks991 (2013). · DOI · Paper page
- Kabsch, W. & Sander, C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577–2637, doi: 10.1002/bip.360221211 (1983). · DOI · Paper page
- O’Boyle, N. M. et al. Open Babel: An open chemical toolbox. J Cheminform 3, 33, doi: 10.1186/1758–2946–3–33 (2011). · DOI · Paper page
- Lazaro, E. et al. Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape. J Clin Invest 121, 2480–2492, doi: 10.1172/JCI44932 (2011). · DOI
- Lee, V. Peptide and protein drug delivery. Vol. 4 (CRC Press, 1990). · DOI · Paper page
- Lin, J. H. & Lu, A. Y. Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev 49, 403–449 (1997). · DOI · Paper page
- Adessi, C. & Soto, C. Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr Med Chem 9, 963–978 (2002). · DOI · Paper page
- Gentilucci, L., De Marco, R. & Cerisoli, L. Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des 16, 3185–3203 (2010). · DOI · Paper page
Cited by
Antimicrobial peptides: Application informed by evolution
Lazzaro, B. P., Zasloff, M., & Rolff, J. (2020) · Science · doi:10.1126/science.aau5480 · Cited by 1,069
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
AntiCP 2.0: an updated model for predicting anticancer peptides
Agrawal, P., Bhagat, D., Mahalwal, M., Sharma, N., & Raghava, G. P. S. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa153 · Cited by 345
Self-citationToxinPred 3.0: An improved method for predicting the toxicity of peptides
Rathore, A. S., Choudhury, S., Arora, A., Tijare, P., & Raghava, G. P. S. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108926 · Cited by 317
Self-citationProtease-Resistant Peptides for Targeting and Intracellular Delivery of Therapeutics
Lucana, M. C., Arruga, Y., Petrachi, E., Roig, A., Lucchi, R., & Oller-Salvia, B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122065 · Cited by 102
Metadata
- Authors
- Mathur, D., Prakash, S., Anand, P., Kaur, H., Agrawal, P., Mehta, A., Kumar, R., Singh, S., & Raghava, G. P. S.
- Venue
- Scientific Reports
- Published
- 2016-11-07
- Volume
- 6
- Issue
- 1
- ISSN
- 2045-2322
- Cited by
- 162
- References
- 6
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PEPlife: A Repository of the Half-life of Peptides. https://app.cochat.ai/papers/10.1038/srep36617
- The paper
- Mathur, D., Prakash, S., Anand, P., Kaur, H., Agrawal, P., Mehta, A., Kumar, R., Singh, S., & Raghava, G. P. S. (2016). PEPlife: A Repository of the Half-life of Peptides. Scientific Reports. https://doi.org/10.1038/srep36617
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.